<p>Graphical representation of striatal CAG instability indices from individual (A) B6, 129, (B6x129).F1 and (B6x129).F2 mice, color-coded based on strain genetic background; and from (B) (B6x129).F2 mice color-coded by genotype at the <i>Mlh1</i>, <i>Msh3</i> and <i>Msh2</i> genes (“undetermined” indicates failed genotype). F2 mice homozygous or heterozygous for B6 <i>Mlh1</i> alleles display significantly higher levels of striatal somatic CAG instability than F2 mice homozygous for 129 <i>Mlh1</i> alleles (<i>p</i><0.0001 for both). No relationship could be established between <i>Msh3</i> or <i>Msh2</i> genotype and striatal CAG instability. B6.<i>Hdh<sup>Q111/+</sup></i>, <i>n</i> = 10, CAG116.9±1.2SD; 129.<i>Hdh<sup>Q111/+</sup></i>, <i...
Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by the expansio...
<div><p>The Huntington's disease gene (<i>HTT</i>) CAG repeat mutation undergoes somatic expansion t...
Background: Successful disease-modifying therapy for Huntington’s disease (HD) will require therapeu...
<p>(A) Representative GeneMapper profiles of <i>HTT</i> CAG repeat size distributions in the tail, s...
<p>(A) Representative GeneMapper profiles of <i>HTT</i> CAG repeat size distributions in the tail, s...
<p>(A) Representative GeneMapper profiles of <i>HTT</i> CAG repeat size distributions in the tail, s...
<p>GeneMapper traces of PCR-amplified <i>HTT</i> CAG repeats from striatum, cortex, liver and tail D...
Huntington’s disease (HD) is an autosomal dominant neurodegenerative disorder caused by the ex...
<div><p>Expansions of trinucleotide CAG/CTG repeats in somatic tissues are thought to contribute to ...
<p>A. ChIP analyses from the striatum and the cerebellum of R6/1 and R6/2 mice using antibody to Me3...
<p>A. Left panel. ChIP analyses from the striatum and the cerebellum of R6/1 and R6/2 mice using ant...
Expansions of trinucleotide CAG/CTG repeats in somatic tissues are thought to contribute to ongoing ...
Huntington\u27s disease is a dominantly inherited neurodegenerative disease caused by the expansion ...
<div><p>Huntington’s disease (HD) is an autosomal dominant neurodegenerative disorder caused by the ...
<p>A. Schematic representation of the HD transgene expressed in R6 mice, showing location of primers...
Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by the expansio...
<div><p>The Huntington's disease gene (<i>HTT</i>) CAG repeat mutation undergoes somatic expansion t...
Background: Successful disease-modifying therapy for Huntington’s disease (HD) will require therapeu...
<p>(A) Representative GeneMapper profiles of <i>HTT</i> CAG repeat size distributions in the tail, s...
<p>(A) Representative GeneMapper profiles of <i>HTT</i> CAG repeat size distributions in the tail, s...
<p>(A) Representative GeneMapper profiles of <i>HTT</i> CAG repeat size distributions in the tail, s...
<p>GeneMapper traces of PCR-amplified <i>HTT</i> CAG repeats from striatum, cortex, liver and tail D...
Huntington’s disease (HD) is an autosomal dominant neurodegenerative disorder caused by the ex...
<div><p>Expansions of trinucleotide CAG/CTG repeats in somatic tissues are thought to contribute to ...
<p>A. ChIP analyses from the striatum and the cerebellum of R6/1 and R6/2 mice using antibody to Me3...
<p>A. Left panel. ChIP analyses from the striatum and the cerebellum of R6/1 and R6/2 mice using ant...
Expansions of trinucleotide CAG/CTG repeats in somatic tissues are thought to contribute to ongoing ...
Huntington\u27s disease is a dominantly inherited neurodegenerative disease caused by the expansion ...
<div><p>Huntington’s disease (HD) is an autosomal dominant neurodegenerative disorder caused by the ...
<p>A. Schematic representation of the HD transgene expressed in R6 mice, showing location of primers...
Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by the expansio...
<div><p>The Huntington's disease gene (<i>HTT</i>) CAG repeat mutation undergoes somatic expansion t...
Background: Successful disease-modifying therapy for Huntington’s disease (HD) will require therapeu...